High-risk gestational trophoblastic neoplasia with brain metastases: Individualized multidisciplinary therapy in the management of four patients

Gynecologic Oncology

Volumn 104, Issue 3, 2007, Pages 691-694

  Soper, J T ^a   Spillman, M ^a   Sampson, J H ^b   Kirkpatrick, J P ^c   Wolf, J K ^d   Clarke Pearson, D L ^a  

^a Laboratory of Gynecologic Oncology   (United States)

^b Division of Neurosurgery   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Brain metastasis; Gestational choriocarcinoma; Gestational trophoblastic neoplasia; High risk gestational trophoblastic neoplasia; Stereotactic radiosurgery; Surgical resection of brain metastases

Indexed keywords

CHORIONIC GONADOTROPIN; CISPLATIN; CYCLOPHOSPHAMIDE; DACTINOMYCIN; DEXAMETHASONE; ETOPOSIDE; FOLINIC ACID; METHOTREXATE; VINCRISTINE;

ADULT; ARTICLE; ARTIFICIAL EMBOLISM; ASSISTED VENTILATION; BLEEDING; BRAIN METASTASIS; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER RISK; CANCER STAGING; CANCER THERAPY; CASE REPORT; COMBINATION CHEMOTHERAPY; CRANIOTOMY; DELIVERY; DRUG DOSE REDUCTION; DYSKINESIA; FEMALE; GRAND MAL SEIZURE; HEADACHE; HEMIPARESIS; HIGH RISK POPULATION; HUMAN; HYSTERECTOMY; INTENSIVE CARE; LIVER METASTASIS; LUNG METASTASIS; MAINTENANCE THERAPY; MORTALITY; MULTIPLE CYCLE TREATMENT; MUSCLE WEAKNESS; NEUROSURGERY; PREGNANCY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIOSURGERY; RESPIRATORY DISTRESS SYNDROME; SALVAGE THERAPY; SCORING SYSTEM; SEPSIS; STEREOTAXIC SURGERY; TROPHOBLASTIC TUMOR; VOMITING;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRAIN NEOPLASMS; CHORIOCARCINOMA; CISPLATIN; CRANIOTOMY; CYCLOPHOSPHAMIDE; DACTINOMYCIN; ETOPOSIDE; FEMALE; FOLIC ACID; GESTATIONAL TROPHOBLASTIC NEOPLASMS; HUMANS; METHOTREXATE; NEOPLASM STAGING; PREGNANCY; RADIOSURGERY; RISK FACTORS; VINCRISTINE;

EID: 33846897798     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2006.10.027     Document Type: Article

References (14)

1. Evans Jr. A.C., Soper J.T., Clarke-Pearson D.L., Berchuck A., Rodriguez G.C., and Hammond C.B. Gestational trophoblastic disease metastatic to the central nervous system. Gynecol. Oncol. 59 (1995) 226-230
2. Newlands E.S., Holden L., Sekl M.J., McNeisch I., Strickland S., and Rustin G.J. Management of brain metastases in patients with high-risk gestational trophoblastic tumors. J. Reprod. Med. 47 (2002) 465-471
3. Ngan H.Y., Bender H., Benedet J.L., Jones H., Montruccoli G.C., and Pecorelli S. FIGO Committee on Gynecologic Oncology: gestational trophoblastic neoplasia, FIGO 2000 staging and classification. Int. J. Gynaecol. Obstet. 83 Suppl. 1 (2003) 175-177
4. Small Jr. W., Lurain J.R., Shetty R.M., Huang C.F., Appelgate G.L., and Brand W.N. Gestational trophoblastic disease metastatic to the brain. Radiology 200 (1996) 277-280
5. Schecter N.R., Mychalczak B., Jones W., and Spriggs D. Prognosis of patients treated with whole brain radiation therapy for metastatic gestational trophoblastic disease. Gynecol. Oncol. 68 (1998) 183-192
6. Leslie M.D., Mangili G., Kemeny A.A., and Newlands E.S. Gestational choriocarcinoma metastatic to the brain treated successfully by stereotactic radiosurgery and chemotherapy. Clin. Oncol. (R Coll Radiol) 8 (1996) 259-260
7. Soper J.T., Evans A.C., Clarke-Pearson D.L., Berchuck A., Rodriguez G.C., and Hammond C.B. Alternating weekly chemotherapy with etoposide-methotrexate-dactinomycin/cyclophos-phamide-vincristine for high-risk gestational trophoblastic disease. Obstet. Gynecol. 83 (1994) 113-117
8. So N.K., O'Neill B.P., Frytak S., Eagan R.T., Earnest F., and Lee R.E. Delayed leukoencephalopathy in survivors with small cell lung cancer. Neurology 37 (1987) 1198-1201
9. Blay J.Y., Conroy T., Chevreau C., et al. High-dose methotrexate for the treatment of primary cerebral lymphomas: analysis of survival and late neurologic toxicity in a retrospective series. J. Clin. Oncol. 16 (1998) 864-871
10. Omura A.M.P., Ben-Porat L.S., Panageas K.S., et al. Delayed neurotoxicity in primary central nervous system lymphoma. Arch. Neurol. 62 (2005) 1595-1600
11. Karim A.B.M.F. Stereotactic irradiations on the horizon: a challenge for multimodal developments. Int. J. Radiat. Oncol. Biol. Phys. 30 (1994) 727-729
12. Soffietti R., Ruda R., and Mutani R. Management of brain metastases. J. Neurol. 249 (2002) 1357-1369
13. Gillespie A.M., Siddiqui N., Coleman R.E., and Hancock B.W. Gestational trophoblastic disease: does central nervous system chemoprophylaxis have a role?. Br. J. Cancer 79 (1999) 1270-1272
14. Tetef M.L., Margolin K.A., Doroshow J.H., et al. Pharmacokinetics and toxicity of high-dose intravenous methotrexate in the treatment of leptomeningeal carcinomatosis. Cancer Chemother. Pharmacol. 46 (2000) 19-26